Inovio Pharmaceuticals In...

1.92
0.05 (2.67%)
At close: Apr 24, 2025, 3:59 PM
1.88
-1.83%
After-hours: Apr 24, 2025, 04:07 PM EDT
2.67%
Bid 1.63
Market Cap 70.23M
Revenue (ttm) 217.76K
Net Income (ttm) -25.25B
EPS (ttm) -3.95
PE Ratio (ttm) -0.48
Forward PE -0.83
Analyst Buy
Ask 2.19
Volume 379,176
Avg. Volume (20D) 709,937
Open 1.86
Previous Close 1.87
Day's Range 1.86 - 1.93
52-Week Range 1.42 - 13.44
Beta 1.84

About INO

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 8, 1998
Employees 134
Stock Exchange NASDAQ
Ticker Symbol INO
Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for INO stock is "Buy." The 12-month stock price forecast is $16.5, which is an increase of 761.62% from the latest price.

Stock Forecasts

Next Earnings Release

Inovio Pharmaceuticals Inc. is scheduled to release its earnings on May 12, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-1.7%
Shares of industrial stocks are trading lower foll... Unlock content with Pro Subscription
3 months ago
+18.13%
Shares of vaccine makers are trading higher after the first bird flu death was reporting in the US. Additionally, a recent CDC report noted an increase in acute respiratory illness activity.